Victoria Socha

DocwireNews

Boston&mdash;Secondary bone complications such as avascular necrosis/osteoporosis are common among transplant recipients. Arthroplasty is the usual treatment of choice. However, acute kidney injury (AKI) often occurs during total arthroplasty, with incidence rates among transplant recipients from 16% to 26%; incidence rates in the general population are as low as 1.1%. There are few data on the underlying reasons why kidney transplant recipients are at increased risk for AKI; the long-term consequences are also unknown.Sorkko Thirunavukkarasu, MD, and Ziad El-Zoghby, MD, of the Mayo Clinic, Rochester, Minnesota, recently conducted a retrospective review of 106 kidney transplant recipients who underwent total hip arthroplasty at the Mayo Clinic between 2000 and 2018. Results of the review were reported during a poster session at the NKF Spring Clinical Meetings in a poster titled Acute Kidney Injury (AKI) in Kidney Transplant Recipients (KTS) Undergoing Total Hip Arthroplasty (THA).Chart review was used to obtain demographic data and clinical information. Current Kidney Disease Improving Global Outcomes criteria were used to define AKI using serial creatinine values prior to surgery (baseline) and within 1 week of surgery. Data on length of stay, exposure to angiotensin-converting enzyme (ACE) inhibitors, angiotensin II receptor blockers (ARBs), and nonsteroidal anti-inflammatory drugs (NSAIDs), and, to assess long-term effects on allograft function, creatinine levels at 1 year after surgery were also collected.At the time of surgery, average age was 59 years; 57% of the cohort were male, and 95% were white. The surgical indications were degenerative joint disease (57%), avascular necrosis (28%), fractures (12%), and miscellaneous (3%).AKI occurred in 11 patients (11%). All were stage 1 per Acute Kidney Injury Network criteria. The cause of AKI was unclear in six patients, three were diagnosed with acute tubular necrosis, and two were presumed to be due to pre-renal etiology. None of the total cohort received ACE/ARBs the day of surgery; two patients received NSAIDs postoperatively, but did not develop AKI.Among the AKI patients, 81% (9/11) had creatinine level return to baseline at discharge. The average length of stay for the patients with AKI was 5.3 days compared with 3.7 days for those who did not develop AKI. There were no differences between the two groups in change in estimated glomerular filtration rate at 1 year post-surgery.&ldquo;The incidence in AKI in kidney transplant recipients after total hip arthroplasty was 11% with recovery to baseline in almost all patients and no difference in allograft function at 1 year,&rdquo; the researchers said.Source: Thirunavukkarasu S, El-Zoghby Z. Acute kidney injury (AKI) in kidney transplant recipients (KTR) undergoing total hip arthroplasty (THA). Abstract of a poster presented at the National Kidney Foundation 2019 Spring Clinical Meetings, May 8-12, 2019, Boston, Massachusetts.

Kaitlyn Kosko

Pembrolizumab Plus Trastuzumab/Pertuzumab Shows Promise in HER2-Positive Breast Cancer

HER2 Breast Cancer

MarkAlain Déry, DO, MPH, FACOI

Autism Rates Reach New High in U.S. Children: Here’s What It Really Means

Neurodivergent

Jordana Jampel

Annual US Measles Cases Top 1,000, Worst Year Since Elimination

Infectious Disease

Latest News

AKI Following Arthroplasty in Transplant Recipients

Acute Kidney Injury

Secondary bone complications such as avascular necrosis/osteoporosis are common among transplant recipients.

About Us

Editorial Policy

Advertising

Contact Us

eNewsletters

Contribute

Career Center

MashupMD

Blood Cancers Today

Cancer Nursing Today

GU Oncology Now

Urban Health Today

Anemia

Deep Vein Thrombosis

Essential Thrombocythemia

Hemophilia

Immune Thrombocytopenic Purpura

Myelodysplastic Syndromes

Myelofibrosis

Myeloproliferative Neoplasms

Polycythemia Vera

Pulmonary Embolism

Sickle Cell Disease

Thrombocytopenia

Thrombophilia

Thrombosis

Thrombotic Thrombocytopenic Purpura

Venous Thromboembolism

von Willebrand Disease

Heme Today

ADPKD

Anemia and Kidney Disease

Chronic Kidney Disease

COVID-19 and Kidney Disease

Diabetes and Hypertension

End-Stage Renal Disease

Gout

Hyperkalemia

IgAN

Kidney Transplantation

Metabolic Acidosis

Nephrology Times

HR Breast Cancer

Triple-Negative Breast Cancer

Genetics & Breast Cancer

Breast Cancers Today

Atherosclerotic Disease

Atrial Fibrillation

Heart Failure

Hypertension

Interventional Cardiology

Lipid Management

Practice Tips With Dr. Lichaa

Preventive Cardiology

Stroke

Cardiology

Breast Cancer

Gynecologic Cancer

Head and Neck Cancer

Skin Cancer

Oncology

Sleep

Urology

Diabetes

Ophthalmology

— Demodex Blepharitis

Neurology

Rheumatology

Gastroenterology

Pulmonology

Infectious Diseases

— HIV

Health and Wellness

Lupus

Future of Medicine

Orthopedics

Pharmacology

Career News

More

Conferences

CardioNerds

The Sleep Source With Dr. Morse

Rheumatology Rounds With Dr. Maheswaranathan

Partners

Expert Interviews

Subscribe